Maurizio Fava
Papers
1
Total Citations
6
H-Index
1
About
Maurizio Fava is a pioneering force in psychopharmacology and the treatment of major depressive disorder (MDD), with a career spanning decades of transformative research. His work centers on developing novel therapeutics for treatment-resistant depression, dissociative symptoms, and the optimization of antidepressant strategies. Among his most notable contributions is the investigation of REL-1017 (esmethadone), a novel N-methyl-D-aspartate (NMDA) receptor modulator that may rapidly reduce dissociative symptoms in adults with MDD unresponsive to standard antidepressants—a finding that opens new avenues for addressing underdiagnosed dissociative states in psychiatric populations. With over 1,200 publications and more than 100,000 citations, Fava’s impact is immense; his research has shaped clinical guidelines and inspired a generation of investigators. As the former Executive Vice Chair of the Department of Psychiatry at Massachusetts General Hospital and a leading figure in the field, he has also been instrumental in landmark studies like STAR*D, which redefined treatment algorithms for depression. Fava’s relentless pursuit of innovative solutions continues to illuminate paths for patients who have exhausted conventional options.
Research Focus
Key Achievements
Top Papers
- 1